Bryan T Durkin insider trades: Cme Group (CME) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Bryan reports to the SEC
Open-market buys and sales
20 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | CME | ↓ Sell | 4,200 | $309.65 | $1.3M | Direct | Feb 23, 2026 (0d) |
| Aug 30, 2024 | CME | ↓ Sell | 7,593 | $214.59 | $1.6M | Direct | Sep 3, 2024 (4d) |
| Dec 11, 2023 | CME | ↓ Sell | 5,560 | $216.37 | $1.2M | Direct | Dec 12, 2023 (1d) |
| Nov 5, 2021 | CME | ↓ Sell | 10,000 | $222.07 | $2.2M | Direct | Nov 8, 2021 (3d) |
| Feb 19, 2021 | CME | ↓ Sell | 11,000 | $195.58 | $2.2M | Direct | Feb 23, 2021 (4d) |
| May 21, 2020 | CME | ↓ Sell | 9,000 | $180.11 | $1.6M | Direct | May 26, 2020 (5d) |
| Aug 6, 2018 | CME | ↓ Sell | 11,509 | $162.01 | $1.9M | Direct | Aug 7, 2018 (1d) |
| Aug 8, 2017 | CME | ↓ Sell | 9,200 | $125.13 | $1.2M | Direct | Aug 9, 2017 (1d) |
| Dec 28, 2016 | CME | ↓ Sell10b5-1 | 14,886 | $116.39 | $1.7M | Direct | Dec 29, 2016 (1d) |
| Nov 30, 2016 | CME | ↓ Sell10b5-1 | 15,000 | $112.85 | $1.7M | Direct | Dec 1, 2016 (1d) |
| Oct 31, 2016 | CME | ↓ Sell10b5-1 | 15,000 | $100.00 | $1.5M | Direct | Nov 1, 2016 (1d) |
| Sep 28, 2016 | CME | ↓ Sell10b5-1 | 14,990 | $105.10 | $1.6M | Direct | Sep 30, 2016 (2d) |
| Sep 6, 2016 | CME | ↓ Sell10b5-1 | 15,000 | $107.75 | $1.6M | Direct | Sep 8, 2016 (2d) |
| Nov 20, 2015 | CME | ↓ Sell10b5-1 | 11,250 | $98.00 | $1.1M | Direct | Nov 24, 2015 (4d) |
| Sep 2, 2014 | CME | ↓ Sell10b5-1 | 25,625 | $76.75 | $2.0M | Direct | Sep 4, 2014 (2d) |
| Feb 22, 2008 | CME | ↓ Sell10b5-1 | 500 | $525.00 | $263K | Direct | Feb 25, 2008 (3d) |
| Jan 30, 2008 | CME | ↓ Sell10b5-1 | 1,375 | $611.50 | $841K | Direct | Feb 1, 2008 (2d) |
| Jan 15, 2008 | CME | ↓ Sell10b5-1 | 1,500 | $616.75 | $925K | Direct | Jan 17, 2008 (2d) |
| Nov 20, 2007 | CME | ↓ Sell10b5-1 | 782 | $649.25 | $508K | Direct | Nov 21, 2007 (1d) |
| Nov 2, 2007 | CME | ↓ Sell10b5-1 | 1,218 | $651.56 | $794K | Direct | Nov 6, 2007 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CME insiders
Open-market trades in the last 12 months
About Bryan T Durkin's insider trades
Bryan T Durkin is a director at Cme Group (CME). Since Nov 2, 2007, Bryan has reported no open-market purchases and 20 sales worth $27.7M on SEC Form 4. In the last 12 months: 1 sale ($1.3M).
12 sales (52% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (32 filings), shares withheld for taxes (23 filings), option exercises (12 filings), gifts (4 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CME insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.